Zlatkovic-Svenda M, Rasic M, Ovuka M, Pavlov-Dolijanovic S, Atanaskovic Popovic M, Ogric M
Biomedicines. 2025; 13(2).
PMID: 40002929
PMC: 11852539.
DOI: 10.3390/biomedicines13020516.
Sabaghian T, Kharazmi A, Omidi F, Hajikhani B, Tehrani S, Mardani S
Immun Inflamm Dis. 2025; 13(2):e70134.
PMID: 39898621
PMC: 11789270.
DOI: 10.1002/iid3.70134.
Ren Z, Xiong R, Wang L, Chen Z, Chen R, Liu Z
Thromb J. 2024; 22(1):99.
PMID: 39516860
PMC: 11549801.
DOI: 10.1186/s12959-024-00669-6.
Sales L, Souza L, Fernandes A, Murai I, Santos M, Vendramini M
Clinics (Sao Paulo). 2024; 79:100474.
PMID: 39208655
PMC: 11399608.
DOI: 10.1016/j.clinsp.2024.100474.
Mellor-Pita S, Tutor-Ureta P, Velasco P, Plaza A, Diego I, Vazquez-Comendador J
Viruses. 2024; 16(7).
PMID: 39066233
PMC: 11281419.
DOI: 10.3390/v16071071.
Antiphospholipid antibody-related hepatic vasculitis in a juvenile after non-severe COVID-19: a case report and literature review.
Li Q, Li J, Zhou M, Ge Y, Liu Z, Li T
Front Immunol. 2024; 15:1354349.
PMID: 38707895
PMC: 11066154.
DOI: 10.3389/fimmu.2024.1354349.
Lupus Anticoagulant Is Associated with Critical Cases and High Mortality in COVID-19: A Literature Review.
Moafi M, Ebrahimi M, Hatami F, Javandoust Gharehbagh F, Ahmadzadeh A, Emam M
Tanaffos. 2023; 22(1):53-60.
PMID: 37920325
PMC: 10618584.
COVID-19 and antiphospholipid antibodies.
Butt A, Erkan D, Lee A
Best Pract Res Clin Haematol. 2022; 35(3):101402.
PMID: 36494152
PMC: 9568270.
DOI: 10.1016/j.beha.2022.101402.
COVID-19 and the antiphospholipid syndrome.
Serrano M, Espinosa G, Serrano A, Cervera R
Autoimmun Rev. 2022; 21(12):103206.
PMID: 36195247
PMC: 9527199.
DOI: 10.1016/j.autrev.2022.103206.
Efficacy and safety of nafamostat mesilate anticoagulation in blood purification treatment of critically ill patients: a systematic review and meta-analysis.
Lin Y, Shao Y, Liu Y, Yang R, Liao S, Yang S
Ren Fail. 2022; 44(1):1263-1279.
PMID: 35930302
PMC: 9359194.
DOI: 10.1080/0886022X.2022.2105233.
A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients.
Gasparini G, Canepa P, Verdiani S, Carmisciano L, Cozzani E, De Grazia D
Int J Immunopathol Pharmacol. 2021; 35:20587384211042115.
PMID: 34541915
PMC: 8460963.
DOI: 10.1177/20587384211042115.
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor.
Gil-Etayo F, Garcinuno S, Lalueza A, Diaz-Simon R, Garcia-Reyne A, Pleguezuelo D
Biomedicines. 2021; 9(8).
PMID: 34440103
PMC: 8389622.
DOI: 10.3390/biomedicines9080899.
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?.
Foret T, Dufrost V, Salomon du Mont L, Costa P, Lefevre B, Lacolley P
Curr Rheumatol Rep. 2021; 23(8):65.
PMID: 34218350
PMC: 8254447.
DOI: 10.1007/s11926-021-01029-3.
Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19.
Cimolai N
SN Compr Clin Med. 2021; 3(10):2093-2108.
PMID: 34179695
PMC: 8218573.
DOI: 10.1007/s42399-021-00992-3.
Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review.
Taha M, Samavati L
RMD Open. 2021; 7(2).
PMID: 33958439
PMC: 8103564.
DOI: 10.1136/rmdopen-2021-001580.
Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?.
Castillo-Martinez D, Torres Z, Amezcua-Guerra L, Pineda C
Clin Rheumatol. 2021; 40(7):3015-3019.
PMID: 33826045
PMC: 8024929.
DOI: 10.1007/s10067-021-05724-5.
Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review.
Tang K, Hsu B, Chen D
Front Immunol. 2021; 12:645013.
PMID: 33777042
PMC: 7994612.
DOI: 10.3389/fimmu.2021.645013.
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.
Novelli L, Motta F, De Santis M, Ansari A, Gershwin M, Selmi C
J Autoimmun. 2021; 117:102592.
PMID: 33401171
PMC: 7833462.
DOI: 10.1016/j.jaut.2020.102592.
COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?.
El Hasbani G, Taher A, Jawad A, Uthman I
Clin Med Insights Arthritis Musculoskelet Disord. 2020; 13:1179544120978667.
PMID: 33328777
PMC: 7720319.
DOI: 10.1177/1179544120978667.
